Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SPRO
#3791
Spero Therapeutics, Inc. Common Stock
2.7
8
USD
0.00%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
0.00%
Mudança mensal
+8.17%
Mudança em 6 meses
+15.83%
Mudança anual
+286.11%
Fechamento anterior
2.7
8
Abrir
2.7
8
Bid
Ask
Mínimo
2.7
8
High
2.7
8
Volume
23
Mercados
Ações
Cuidados de saúde
SPRO
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
29.5 M
32.76 M
52.57 M
53.87 M
55.9 M
57.89 M
—
Valuation ratios
Enterprise value
494.9 M
419.31 M
-10.89 M
11.18 M
8.99 M
97.61 M
278.28 M
Price to earnings ratio
—
—
-1.41
3.53
-0.81
15.53
9.63
Price to sales ratio
—
—
1.22
0.78
1.16
2.06
8.77
Price to cash flow ratio
—
—
-8.46
-2.44
-2.37
-10.9
-20.69
Price to book ratio
—
—
0.86
0.75
1.21
2.33
4.14
Enterprise value to EBITDA ratio
-6.21
-4.72
0.43
0.25
-0.06
14.99
—
Profitability ratios
Return on assets %
-0.51
-0.52
-0.37
0.13
-0.62
0.12
0.12
Return on equity %
-0.59
-1.02
-0.61
0.21
-1.49
0.15
-0.21
Return on invested capital %
-1 225.35
-1 563.16
-698.97
122.86
-412.12
74.11
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-847.94
-481.87
-78.86
20.7
-152.91
9.45
-337.42
EBITDA margin %
-839.79
-478.34
-77.24
21.05
-152.9
9.45
—
Net margin %
-839.23
-491.89
-86.74
21.98
-142.91
12.83
-307.36
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
9.7
8.46
5.25
3.53
2.19
7.59
17.96
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.11
0.36
0.68
0.33
0.74
1.03
Solvency ratios
Debt to assets ratio
0.05
0.04
0.05
0.03
0.04
0.04
—
Debt to equity ratio
0.06
0.08
0.09
0.05
0.09
0.05
—
Long term debt to total assets ratio
0
0
0
0
0
0
—
Long term debt to total equity ratio
0
0
0
0
0
0
—
Per share metrics
Operating cash flow per share
—
—
-0.21
-0.62
-0.43
-0.21
-0.22
EBIT per share
—
—
-1.12
0.41
-1.36
0.11
0.08
EBITDA per share
—
—
-1.1
0.41
-1.36
0.11
—
Total debt per share
—
—
0.18
0.11
0.08
0.05
—
Cash per share
—
—
2.9
1.44
0.98
0.68
2.99
Net current asset value per share
—
—
3.02
2.48
1.99
1.14
4.48
Tangible book value per share
—
—
2.02
2.02
0.85
1
2.67
Working capital per share
—
—
2.45
1.77
1.08
0.99
3.29
Book value per share
—
—
2.02
2.02
0.85
1
2.67
Notícias
Ações da Spero Therapeutics sobem mais de 4% com resultados do quarto trimestre acima do esperado
Lucro da Spero Therapeutics superou projeções por $0,73; receita supera estimativas
Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)
Keutzer, COO da Spero Therapeutics, vende ações no valor de US$ 44 mil
Keutzer, Spero Therapeutics COO, sells $44k in shares
CEO da Spero Therapeutics vende ações no valor de US$ 207 mil
Spero Therapeutics CEO sells $207k in stock
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
Spero Therapeutics announces board resignation and SEC investigation closure
GSK files NDA resubmission for Spero’s tebipenem HBr antibiotic
Lucro da Spero Therapeutics superou projeções por $0,26; receita menor do que estimativas
Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates